The PORTOS assay could indicate when or when not to offer dose-escalated radiation for localized prostate cancer.

The following is a summary of “Application of mean maximum Young’s modulus value as a new parameter for differential ...

The National Cancer Audit Collaborating Centre said prostate, kidney and colon cancers were the worst affected with ...

A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes.

For those unlucky enough to have received a testicular castration to treat prostate cancer, only for it to come back, Clarity Pharmaceuticals’ (ASX:CU6) news on Wednesday morning could offer crucial ...

Providence Alaska Medical Center will be the first in the state to offer Pluvicto, an innovative therapy for metastatic ...

Nearly one in eight men will be diagnosed with prostate cancer and, as a new UCSF study finds, significantly more of these ...

A "Man Van" deployed in disadvantaged communities can help identify men at high risk for prostate cancer, according to a ...

Serum testosterone (T) recovery to normal levels is associated with a significant improvement in overall survival in patients ...

Radium-223 is an alpha-emitting radiopharmaceutical that accumulates in areas of high bone turnover and has demonstrated a survival benefit in metastatic prostate cancer, 1 but its benefits as a ...

(UroToday.com) The 2025 GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Ivan de Kouchkovsky discussing the impact of baseline PSMA PET in patients with metastatic ...